Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for ...

Linda Jónsdóttir Linda Jonsdottir, Alvotech's new Chief Financial Officer REYKJAVIK, ICELAND (July 10, 2025) — Alvotech ...

Alvotech stock has dropped despite strong fundamentals and rapid sales growth. Read about ALVO's projected revenue, debt ...

Alvotech acquires Swiss packaging firm Ivers-Lee to boost biosimilar production capacity ahead of three 2025 launches.

Alvotech, a global biotech company specializing in the development and manufacture of biosimilars, has appointed Linda ...

Alvotech ( NASDAQ: ALVO) is expanding its capacity for assembly and packaging with the acquisition of Ivers-Lee Group. Based in Burgdorf, Switzerland, Ivers-Lee provides assembly and packaging ...

Alvotech does not undertake any duty to update these forward-looking statements or to inform the recipient of any matters of which any of them becomes aware of which may affect any matter referred ...

Alvotech does not undertake any duty to update these forward-looking statements or to inform the recipient of any matters of which any of them becomes aware of which may affect any matter referred ...

--Alvotech, a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the appointment of Linda Jónsdóttir as Chief ...

Alvotech and Advanz Pharma expand their European biosimilar partnership to include AVT10, targeting Cimzia® for rheumatic ...

REYKJAVIK, ICELAND and LONDON, UK (July 1, 2025) - Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and ...